Ibuprofeno Pensa

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Ibuprofeno Pensa

Quick Facts: Ibuprofeno Pensa Identity

Property Description
Active ingredient Ibuprofen
Form Tablet (Coated/Film-coated)
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General purpose Relieves pain, inflammation, and fever
Origin Synthetic compound

What is Ibuprofeno Pensa?

Ibuprofeno Pensa is the trade designation for a medicine whose sole active ingredient is Ibuprofen. This compound is formally classified within the core pharmacological class of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). Ibuprofen is a synthetic compound derived from propionic acid, and its mechanism is clinically recognized for its broad application in managing discomfort by reducing inflammatory pathways.


What Type of Medicine is Ibuprofeno Pensa?

This product is a single product (monosemantic drug), containing only the active substance Ibuprofen. As a synthetic compound, it is typically delivered via the oral route of administration in a solid dose, often manufactured as a coated tablet or film-coated tablet. The composition includes the active substance plus necessary solid pharmaceutical excipients as the base. The Pensa brand often positions its products for general use, providing a standardized, convenient oral form that may be available in various market strengths.


What is the General Purpose of Ibuprofeno Pensa?

The general purpose of Ibuprofeno Pensa is to provide temporary relief by addressing symptoms related to pain, inflammation, and fever. Oral ibuprofen is used for acute pain management. The drug’s utility is therefore universally established, with its targeted action allowing it to serve three distinct, high-level benefits: an analgesic effect (relief from pain signals), an anti-inflammatory effect (reducing swelling and redness), and an antipyretic effect (lowering high body temperature).

Advertisements

What side effects are possible with Ibuprofeno Pensa?

Possible Side Effects and Safety Information

Official regulatory documents classify the safety profile of Ibuprofeno Pensa by grouping possible adverse reactions by frequency and affected body system (System-Organ Class).

Key Adverse Reaction Categories

Adverse effects commonly involve the Gastrointestinal System, including stomach discomfort, ulcers, bleeding, and potentially fatal perforation. Other system classes of concern include Cardiovascular Disorders, Nervous System Disorders (such as headache), and Skin and Subcutaneous Tissue Disorders.

Frequency Classification Examples (Non-exhaustive)
Common Gastrointestinal disturbances, nausea, headache, dizziness, rash.
Uncommon Hypersensitivity reactions (e.g., urticaria), certain liver function disturbances.
Very Rare Severe skin reactions (e.g., Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis), severe allergic reactions (anaphylaxis), kidney failure, severe blood disorders.

Serious Adverse Reaction Warnings and Restrictions

  • Cardiovascular Risk: Nonsteroidal Anti-inflammatory Drugs (NSAIDs) like ibuprofen increase the risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke. This risk can occur early in treatment and may be greater with higher doses (2,400 mg per day or more) and longer duration of use.
  • Gastrointestinal Risk: The risk of serious adverse gastrointestinal events, such as bleeding, ulceration, and perforation, may also be dose- and duration-dependent.
  • Contraindications: The medicine is formally contraindicated (must not be used) in patients with severe heart failure, active gastrointestinal bleeding or ulceration, and in the setting of coronary artery bypass graft (CABG) surgery.
  • Pregnancy: Use of NSAIDs is restricted at 20 weeks or later in pregnancy due to the potential for serious fetal kidney problems and low amniotic fluid.

The regulatory safety structure mandates that the lowest effective dose be used for the shortest duration possible to minimize the potential for both gastrointestinal and cardiovascular risks. Patients with pre-existing heart disease, high blood pressure, or a history of gastrointestinal problems are identified in regulatory documentation as having a potentially increased risk.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The regulatory profile for Ibuprofen overdose is strictly defined by documented clinical manifestations and mandated emergency actions, consistent with government prescribing information.

Element Official Regulatory Description
Documented Overdose Presentations Symptoms include Gastrointestinal effects (Nausea, Vomiting, Stomach pain) and Central Nervous System (CNS) effects (Drowsiness, Dizziness, Headache, Tinnitus, Confusion). Cardiovascular and Respiratory changes, such as hypotension, bradycardia, and apnoea (cessation of breathing), are also documented.
Population-specific Overdose Notes Overdose has been specifically described in infants and children, where manifestations may include CNS depression, seizures, and apnoea.
When Immediate Medical Help is Required Official instructions mandate to seek immediate medical attention by contacting the local emergency number or poison control center immediately upon suspected overdose, especially for severe toxicity signs like seizures or loss of consciousness.

Overdose Management Profile

Official overdose statements:

  • Severe outcomes associated with overdose include acute renal failure, metabolic acidosis, seizures, and coma.
  • No specific antidote is available; management is required to be symptomatic and supportive.
  • Supportive measures include the use of activated charcoal, gastric lavage, and monitoring of vital signs and renal function.
  • Hospital observation is required following ingestion to monitor the patient for a period of time.

Connection to the overall overdose profile: Regulatory documents define the official overdose profile by detailing the severe multi-system clinical manifestations and mandating a non-negotiable emergency-response statement requiring immediate contact with medical services for suspected ingestion. This profile further requires management to be entirely symptomatic and supportive due to the confirmed absence of a specific antidote, necessitating close monitoring and treatment of resulting complications.

Advertisements

Therapeutic Uses of Ibuprofeno Pensa

The primary therapeutic benefit of Ibuprofeno Pensa is generally applied to help manage symptomatic discomfort across three core domains: pain, inflammation, and fever. Its application is considered relevant when supportive symptom management may be needed during acute or recurrent episodes. This medicine is applied in clinical settings that involve acute or unstable symptom patterns, helping to address symptom clusters that may become intense or disruptive.

Ibuprofeno Pensa is commonly used to help with symptoms related to physical discomfort like headaches, toothache, and menstrual pain (dysmenorrhea), as well as systemic symptoms of the cold or flu. It is also applied in conditions involving inflammatory states and is relevant for easing discomfort and stiffness associated with osteoarthritis, rheumatoid arthritis, minor sprains, and strains.

“The primary goal is to help maintain a sense of stability when symptoms are more noticeable, assisting with easing the overall symptom load.”

This supportive relief helps patients cope more steadily with symptom fluctuations and contributes to general well-being during symptomatic phases.


Quick Fact: Relief for Heightened Symptoms

Symptom Category Condition Example Therapeutic Benefit
Pain (Physical Discomfort) Menstrual Pain, Toothache, Headache Helps ease intensity and discomfort
Inflammation (Irritative States) Arthritis, Sprains, Strains Supports functional stability during symptomatic periods
Fever (Systemic Imbalance) Cold or Flu Symptoms Contributes to easing elevated body temperature

Regulatory References

  1. National Institutes of Health (NIH) data
Advertisements

Eligibility and Restrictions for Use

Eligibility for Ibuprofeno Pensa

Ibuprofeno Pensa is generally allowed for adults and adolescents aged 12 years and above (or ge40 kg body weight), according to official regulatory documentation. However, its use is contraindicated for several specific populations and conditions.

Contraindicated Populations and Conditions:

  • Allergy/Sensitivity: Patients with hypersensitivity to ibuprofen, excipients, or those who have had asthma, urticaria, or allergic reactions after taking aspirin or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
  • Gastrointestinal Risk: Individuals with active or recurrent peptic ulcer/hemorrhage, a history of gastrointestinal bleeding or perforation related to prior NSAID use, or active bleeding (e.g., cerebrovascular).
  • Organ Failure: Patients with severe heart failure (NYHA Class IV), severe renal failure, or severe hepatic failure.
  • Cardiovascular: Patients immediately before or after coronary artery bypass graft (CABG) surgery.
  • Age and Physiological State: Use is contraindicated during the third trimester of pregnancy and breastfeeding. It is generally not recommended for children under 12 years.

Use Requires Special Consideration (Caution/Restriction):

Patients with mild-to-moderate renal, hepatic, or heart failure (NYHA Class II-III), uncontrolled hypertension, established cardiovascular disease, or gastrointestinal history (like Crohn's disease or ulcerative colitis) must use this medicine only after careful assessment. Elderly patients are also at increased risk and should use the lowest effective dose for the shortest period.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Ibuprofen documents several clinically significant interaction patterns across various medicine categories and substances.

Formal Interaction Restrictions

Co-administration with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), including selective COX-2 inhibitors, is formally contraindicated due to an additive risk of serious gastrointestinal adverse events. Use is also restricted for managing peri-operative pain in the context of Coronary Artery Bypass Graft (CABG) surgery. Additionally, a risk of significant bleeding is documented for chronic, heavy consumption of alcohol when combined with this medicine.

Documented Pharmacological Interactions

Interaction Type Interacting Medicines / Outcome
Pharmacodynamic (PD) Risk Anticoagulants (e.g., Warfarin), Corticosteroids, and SSRIs carry an additive risk of bleeding and gastrointestinal ulceration. Ibuprofen may reduce the efficacy of Antihypertensives and Diuretics.
Pharmacokinetic (PK) Risk Ibuprofen decreases the renal clearance of drugs like Lithium and Methotrexate, leading to increased plasma concentration and systemic exposure of these agents.

Administration Requirements

To mitigate potential interference with its antiplatelet effect, a specific timing separation rule is required when co-administering Ibuprofen with low-dose Aspirin used for cardiovascular protection. Furthermore, elderly patients and those with pre-existing renal or hepatic impairment are noted to be at a higher risk for adverse outcomes from these documented drug interactions.

Advertisements

Mechanism of Action

The mechanism of Ibuprofeno Pensa is centered on enzyme inhibition to modulate specific physiological processes, resulting in specific physiological adjustments to the body's signaling pathways.

u1f52c Modulating Chemical Signals via Cyclooxygenase (COX) Inhibition

The drug works by acting as a non-selective competitive inhibitor of the Cyclooxygenase (COX) enzymes ( COX-1 and COX-2). By reversibly blocking the active sites of these enzymes, the medicine suppresses the conversion of arachidonic acid into prostaglandins—powerful local chemical mediators. This action modifies early molecular steps that shape systemic physiological outcomes, leading to a decrease in the concentration of local signaling mediators.


️ Adjusting Central and Peripheral Pathway Sensitization

This core inhibition leads to two distinct physiological adjustments: peripheral sensitization and central thermoregulation. Locally, the lowered prostaglandin concentrations decrease the excitability of peripheral nociceptors, while centrally, the same reduction in the hypothalamus reverses the elevation of the body's temperature set point. These combined effects influence the regulation of elevated physiological signaling and contribute to the establishment of a normalized physiological set point within the targeted pathways.

Advertisements

Dosage and Administration Information

How to Use Ibuprofeno Pensa

Ibuprofeno Pensa is intended for oral administration only, typically delivered as a film-coated tablet. Standard administration instructions emphasize using the lowest effective dose for the shortest duration necessary to manage symptoms. The tablet should always be swallowed whole with a glass of fluid, and should not be crushed, broken, or chewed.

It is generally recommended to take the medicine with or immediately after food to facilitate proper intake.


Official Dosing and Scheduling Principles

Feature General Principle
Standard Single Dose 200 mg to 400 mg for acute use in adults and adolescents (age geq 12)
Dosing Frequency Doses are repeated only as needed, maintaining an interval of 4 to 6 hours between administrations.
Maximum Daily Dose Generally restricted to 1,200 mg for non-prescription regimens, or up to 3,200 mg for prescription-aligned use in divided doses.
Duration Limit Use should be limited to 10 days for pain or 3 days for fever unless specific professional guidance is provided.

Population-Specific Use

Ibuprofen tablets are typically not used for children under 12 years of age or below 40 kg, as alternative formulations and weight-based dosing are usually necessary. For older adults and patients with mild to moderate kidney or liver function changes, official labeling advises using the lowest effective dose for the shortest duration.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence Overview

Research regarding non-steroidal anti-inflammatory drugs (NSAIDs) like Ibuprofeno Pensa primarily focuses on refining their use for pain, fever, and inflammation, while also characterizing their long-term safety profile. The mechanism of action is understood to involve the non-selective, reversible inhibition of cyclooxygenase (COX) enzymes, which are responsible for the synthesis of prostaglandins, chemical mediators involved in pain and inflammation.


Efficacy and Analgesic Effects

Clinical trials have investigated the effectiveness of ibuprofen for various pain conditions. Cochrane reviews support the use of NSAIDs for short-term symptomatic relief in patients experiencing acute low back pain and for treating symptoms of inflammatory diseases such as rheumatoid arthritis and osteoarthritis. Studies comparing ibuprofen to other analgesics have, in some contexts, found marginal differences in efficacy for treating fever, suggesting that the effectiveness of the treatment may be comparable to alternatives. Research is ongoing to assess the efficacy and safety of new formulations, such as extended-release versions, in managing post-operative dental pain.


Long-Term Safety and Cardiovascular Risk

Extensive research, including large-scale meta-analyses, has examined the risks associated with the long-term use of ibuprofen. The risk of serious cardiovascular thrombotic events, such as myocardial infarction and stroke, may be increased with prolonged use at high doses (e.g., 2400 mg per day or higher). No increased cardiovascular risk has been generally found for non-prescription doses (up to 1200 mg per day) taken for a short duration. Regulatory bodies continually assess this data to ensure the drug's benefits, when used as recommended, outweigh the potential risks. Analysis of research findings also confirms that the most common adverse events relate to gastrointestinal irritation, which may be managed by appropriate administration.

Key Studies & References

  1. Mechanism of Action and Clinical Efficacy of Ibuprofen: A Review
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ibuprofeno Pensa (FAQ)


Q: Is Ibuprofeno Pensa the same type of medicine as regular ibuprofen?

Ibuprofeno Pensa contains Ibuprofen as its sole active ingredient, which is the same core drug substance found in other medicines known as ibuprofen. The difference lies in the trade designation (Pensa) and the other inactive components (excipients) included in the final product formulation.


Q: Is it common to feel tired or dizzy after taking Ibuprofeno Pensa?

Official regulatory safety profiles classify dizziness and headache as common undesirable effects. Other central nervous system effects, such as drowsiness or lethargy (related to feeling tired), have also been noted in post-marketing and clinical data.


Q: Is it described anywhere that Ibuprofeno Pensa can cause an allergic reaction?

Regulatory documents state that the medicine is contraindicated in patients with a known hypersensitivity (allergic reaction) to Ibuprofen or other NSAIDs. While mild hypersensitivity reactions, such as hives, are classified as uncommon, severe allergic reactions (anaphylaxis) are classified as very rare.


Q: Why do people sometimes say to take Ibuprofeno Pensa with food?

Regulatory documents describe administration of the medicine with or immediately after food to help reduce the risk of potential gastrointestinal irritation and side effects. This guidance is in place because NSAIDs, as a class, can be irritating to the stomach lining.


Q: What does official guidance say about Ibuprofeno Pensa use during pregnancy?

Regulatory guidance restricts the use of NSAIDs like Ibuprofen starting at 20 weeks of pregnancy due to the potential for serious fetal kidney problems and low amniotic fluid. Use is explicitly contraindicated (must not be used) during the third trimester of pregnancy.


Q: Can Ibuprofeno Pensa be used during breastfeeding?

The drug is listed as contraindicated for use during breastfeeding in regulatory product documentation. This is a classification based on the drug's properties and potential risk, though studies show that only extremely low levels of the active ingredient may pass into breastmilk.


Q: Why is it important to check drug labels for other medicines containing ibuprofen when taking Ibuprofeno Pensa?

Official regulatory information addresses co-administering multiple products that contain ibuprofen or other NSAIDs. This co-administration is contraindicated due to an additive risk of serious side effects, particularly affecting the gastrointestinal system.


Q: What kind of non-drug interactions are mentioned for Ibuprofeno Pensa (e.g., alcohol)?

Official regulatory information specifically documents a risk of significant gastrointestinal bleeding with chronic, heavy consumption of alcohol when combined with this medicine. Other non-drug interactions are not typically required to be listed on standard product information.


Q: How quickly can someone expect Ibuprofeno Pensa to start working?

The oral form of ibuprofen is generally described in authoritative pharmacokinetic data as having an onset of action in approximately 30 to 60 minutes.


Q: How long does the effect of Ibuprofeno Pensa usually last?

The analgesic effect (pain relief) of Ibuprofen is generally described in authoritative sources as lasting approximately 6 to 8 hours.


Q: Are there different strengths or versions of Ibuprofeno Pensa available?

Ibuprofen, the active ingredient, is manufactured and made available in the market in a variety of strengths (doses) and dosage forms (such as tablets, capsules, or suspensions). The specific strengths and versions available under the Ibuprofeno Pensa trade designation depend on local regulatory approval.


Q: How often is Ibuprofeno Pensa typically used for chronic pain conditions?

Regulatory documents emphasize that NSAIDs should be used at the lowest effective dose for the shortest duration possible. Use extending beyond the limits specified for acute pain (typically 10 days) requires careful assessment, as dose- and duration-dependent risks may increase.


Q: Is Ibuprofeno Pensa ever used to treat migraine headaches?

Ibuprofen is included in regulatory documents as an approved indication for the temporary relief of pain associated with various conditions. This includes headache and migraine headache for some formulations.


Q: Does Ibuprofeno Pensa affect blood pressure?

Regulatory warnings note that the drug may cause fluid retention and potentially elevated blood pressure. Official labeling identifies patients with uncontrolled hypertension or other cardiovascular risk factors as having a potentially increased risk, particularly at higher doses.


Q: What should be done if an adverse event is suspected after taking Ibuprofeno Pensa?

Official guidance describes a system for reporting any suspected adverse reactions to the product. This reporting is typically handled through the national health authority's pharmacovigilance program or directly to the medicine's distributor, following local procedures.


Q: What are the descriptive guidelines for who should avoid Ibuprofeno Pensa?

The medicine is contraindicated (must be avoided) in individuals with specific conditions described in regulatory documents. These include a known allergy to NSAIDs, active gastrointestinal issues (ulcers/bleeding), severe failure of the heart, liver, or kidneys, and use during the third trimester of pregnancy.


Q: Is there guidance on using Ibuprofeno Pensa for symptoms of the common cold?

Regulatory documents state the medicine is generally used for the relief of symptoms related to pain, fever, and inflammation. Since these symptoms may accompany a common cold, the medicine is described for use in managing them.


Q: Is Ibuprofeno Pensa described as being effective for menstrual pain?

Ibuprofen is included in regulatory documents as an approved indication for the temporary relief of pain associated with various conditions. This includes menstrual pain (dysmenorrhea).


Q: How is Ibuprofeno Pensa described in terms of safety for patients with liver disease?

The medicine is contraindicated (must not be used) in patients with severe hepatic failure (liver failure). Official labeling describes that patients with pre-existing mild-to-moderate liver function changes should use the medicine at the lowest effective dose for the shortest duration.


Q: Why is the mechanism of action sometimes described as blocking certain substances in the body?

The technical mechanism of action is described as non-selective competitive inhibition of enzymes that suppress the production of prostaglandins. Prostaglandins are local chemical mediators that play a central role in pain and inflammation, and this suppression of their production is often simplified as 'blocking' them.


Q: Is it accurate that Ibuprofeno Pensa should be used for the shortest time possible?

Official regulatory safety structures describe a requirement for the medicine to be used at the lowest effective dose for the shortest duration possible. This principle is intended to minimize the potential for both cardiovascular and gastrointestinal risks, which can be dose- and duration-dependent.


Q: Are there specific warnings about driving or operating machinery while using Ibuprofeno Pensa?

Although many people experience no impairment, the official safety profile includes side effects such as dizziness and headache. Regulatory advisory information states that users should be aware of how the medicine affects them before attempting to drive or operate machinery.


Q: What are the primary therapeutic uses of Ibuprofeno Pensa described by regulatory bodies?

The primary therapeutic uses described in regulatory documents are based on the drug's three effects: its analgesic effect (relieving pain), anti-inflammatory effect (reducing inflammation), and antipyretic effect (reducing fever).


Q: Are there any reports or studies on the use of Ibuprofeno Pensa in adolescents?

While use is allowed in adolescents aged 12 and over, scientific studies have been conducted and documented—such as those registered on ClinicalTrials.gov—to investigate the efficacy and tolerability of oral ibuprofen in this population for specific conditions.

Advertisements

How should Ibuprofeno Pensa be stored and disposed of?

How to Store and Dispose of Ibuprofeno Pensa

Ibuprofeno Pensa requires storage under specific environmental and container conditions to maintain its quality. The medicine must be stored at a temperature below 25°C and should be protected from light.

Storage Requirements

Condition Regulatory Requirement
Temperature Store below 25°C
Container Keep in the original container and outer carton
Child Safety Store out of the sight and reach of children
Stability Do not use after the expiry date

Disposal

Official instructions prohibit discarding this medicine via wastewater or with household waste. Unused product or waste materials must be disposed of in accordance with local requirements for pharmaceutical waste handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibuprofeno Pensa found in:

A-Z Index: